Swanbridge Capital’s investment strategy is to invest in Life Sciences & Health companies at an early stage. Swanbridge Capital will primarily invest in the form of equity capital.
- The company is active in the LSH sector, within the fields of therapeutics, diagnostics and medical devices;
- The company is located in the Netherlands;
- The company meets the conditions of the Seed Capital scheme